Melanoma International Collaborative Adaptive Trials: Progress Report
The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…
11/13/2018
Melanoma International Collaborative Adaptive Trials: Progress Report
The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…
|
|
11/13/2018
The Melanoma Tissue Bank: Progress Report
As we look back through 2018, perhaps the most exciting news from AIM at Melanoma is the progress on what…
|
|
09/04/2018
Q&A With Three Leading Melanoma Specialists
Eric D. Whitman, MD Medical Director, Atlantic Health System Cancer Care Director, Atlantic Melanoma Center Question: Which clinical trials do…
|
04/27/2018
Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute
Dr. Omid Hamid is recognized nationally and internationally as a key opinion leader in Immuno-Oncologic Drug Development and Melanoma…
|
Recent Posts
Apr. 16, 2024
Navigating the Journey Together – Conversations with Melanoma Caregivers
Apr. 12, 2024
May is Brain Tumor Awareness Month
Apr. 11, 2024
President’s Letter | April 2024
Apr. 11, 2024
Celebrating a Milestone: 20 Years of the Dallas Steps Against Melanoma Walk
Apr. 11, 2024